NeuroPointDx

504 S. Rosa Road
Suite 150
Madison
Wisconsin
53719
United States

Tel: 608-204-0104

Email: contact@NeuroPointDx.com

Show jobs for this employer

About NeuroPointDx

NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and reproducible proprietary platform for identifying changes in metabolism (“biomarkers”) utilizing highly sensitive analytical equipment and its proprietary platform technology. The Company’s diagnostics division, NeuroPointDX, identifies biomarkers of neurological disorders in cellular models of disease and human samples. These biomarkers provide greater insight into the pathways that are disrupted in patients with neurological disorders. This information can be translated into clinical diagnostics, individualized treatment recommendations, and new potential therapies.
LEADERSHIP:
CEO: Elizabeth Donley
FOLLOW NEUROPOINTDX:

6 articles with NeuroPointDx